Abstract GS2-09: Tamoxifen instigates uterine cancer development by activating PI3K signaling and supersedes PIK3CA driver mutations. Kubler, K., Nardone, A., Anand, S., Gorvich, D., Droog, M., Hermida-Prado, F., Akshi, T., Feit, A. S, Cohen, G., Dackus, G., & others Cancer Research, 82(4_Supplement):GS2–09, The American Association for Cancer Research, 2022.
bibtex   
@article{kubler2022abstract,
  title={Abstract GS2-09: Tamoxifen instigates uterine cancer development by activating PI3K signaling and supersedes PIK3CA driver mutations},
  author={Kubler, Kirsten and Nardone, Agostina and Anand, Shankara and Gorvich, Daniel and Droog, Marjolein and Hermida-Prado, Francisco and Akshi, Tara and Feit, Avery S and Cohen, Gabriella and Dackus, Gwen and others},
  journal={Cancer Research},
  volume={82},
  number={4\_Supplement},
  pages={GS2--09},
  year={2022},
  publisher={The American Association for Cancer Research}
}

Downloads: 0